Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A Phase II Trial of Myeloablative I-131-Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Transplantation for B-Cell Non-Hodgkin9s Lymphoma
Blood (2012)
  • Ajay K. Gopal, University of Washington
  • Ted A. Gooley, Fred Hutchinson Cancer Research Center
  • Joseph Rajendran, University of Washington
  • John M. Pagel, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Andrew Shields, University of Washington
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
November 16, 2012
Citation Information
Ajay K. Gopal, Ted A. Gooley, Joseph Rajendran, John M. Pagel, et al.. "A Phase II Trial of Myeloablative I-131-Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Transplantation for B-Cell Non-Hodgkin9s Lymphoma" Blood Vol. 120 Iss. 21 (2012) p. 811 - 811
Available at: http://works.bepress.com/john-pagel/153/